Progress in the seasonal variations of blood lipids: a mini-review. by Ma, Xiaochun et al.
Providence St. Joseph Health 
Providence St. Joseph Health Digital Commons 
Articles, Abstracts, and Reports 
5-25-2020 





Medical Data Research Center, Providence Health and Services, Portland, OR, USA 
Qunye Zhang 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.psjhealth.org/publications 
 Part of the Cardiology Commons 
Recommended Citation 
Ma, Xiaochun; Yan, Haichen; Zhang, Haizhou; Wang, Mansen; Zhang, Qunye; and Zhou, Xiaoming, 
"Progress in the seasonal variations of blood lipids: a mini-review." (2020). Articles, Abstracts, and 
Reports. 3190. 
https://digitalcommons.psjhealth.org/publications/3190 
This Article is brought to you for free and open access by Providence St. Joseph Health Digital Commons. It has 
been accepted for inclusion in Articles, Abstracts, and Reports by an authorized administrator of Providence St. 
Joseph Health Digital Commons. For more information, please contact digitalcommons@providence.org. 
Authors 
Xiaochun Ma, Haichen Yan, Haizhou Zhang, Mansen Wang, Qunye Zhang, and Xiaoming Zhou 
This article is available at Providence St. Joseph Health Digital Commons: https://digitalcommons.psjhealth.org/
publications/3190 
REVIEW Open Access
Progress in the seasonal variations of blood
lipids: a mini-review
Xiaochun Ma1†, Haichen Yan2†, Haizhou Zhang1, Mansen Wang3*, Qunye Zhang4* and Xiaoming Zhou5*
Abstract
The seasonal variations of blood lipids have recently gained increasing interest in this field of lipid metabolism.
Elucidating the seasonal patterns of blood lipids is particularly helpful for the prevention and treatment of
cardiovascular and cerebrovascular diseases. However, the previous results remain controversial and the underlying
mechanisms are still unclear. This mini-review is focused on summarizing the literature relevant to the seasonal
variability of blood lipid parameters, as well as on discussing its significance in clinical diagnoses and management
decisions.
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Introduction
In the last decades, the cardiovascular and cerebrovascu-
lar diseases have become the most prevalent causes of
mortality and morbidity worldwide [1]. Amongst all the
potential risk factors, dyslipidemia has long been recog-
nized to play a crucial role in the initiation and develop-
ment of cardio-cerebrovascular diseases [2, 3]. The
seasonal variations of blood lipids might be a vital con-
tributor to the seasonal alterations in the mortality and
morbidity of these diseases [4]. An array of studies have
reported the seasonal changes in the levels of plasma or
serum lipids [5–7], which has also been described by the
European Atherosclerosis Society (EAS) and the European
Society of Cardiology (ESC) in their joint dyslipidemia
guidelines [8]. The evaluation of seasonal variations in the
lipid profile will be (Delete: is hopefully) considered as a
necessity in stratifying risk profiles and identifying high-
risk population in near future. However, the seasonal dy-
namics of various lipid parameters, including triglyceride
(TG), cholesterol, low-density lipoprotein cholesterol
(LDL-C) and high-density lipoprotein cholesterol (HDL-
C), are still undetermined [9–11]. In this mini-review, we
collected the relevant literature and summarized the
current knowledge about the dynamic changes of LDL-C,
HDL-C, TG and cholesterol through the seasons. We also
sought to discuss the seasonal effects of lipids on routine
clinical practice (Table 1).
Publication search and inclusion
Eligible studies were searched in the PubMed database
which satisfied the following criteria: (A) published ran-
domized control trials (RCTs) or observational studies in
English language; (B) focused on the seasonal variability
of blood lipids including LDL-C, HDL-C, cholesterol
and triglyceride; (C) availability of data required for ana-
lysis. Exclusion criteria were: (a) case reports, editorial
comments and review articles; (b) studies currently un-
derway or with insufficient data. Three authors (Xiao-
chun Ma, Haichen Yan and Xiaoming Zhou)
independently searched the PubMed databases for re-
trieval of eligible studies published from inception to
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December 2018. The search terms used included the
“seasonal variations”, “seasonal pattern”, “seasonal vari-
ability”; “seasonal alteration”; “seasonal change”; “sea-
sonal dynamics”; “seasonal effect”; “seasonality”;
“seasonal difference”; “seasonal trend”; and “seasonal
transformation” of blood lipids. The three corresponding
authors also manually examined the references from re-
trieved articles for articles meeting the criteria. The ab-
stracts of retrieved articles were subsequently checked
separately by Xiaochun Ma and Haichen Yan. Next, the
full-text articles potentially included in this mini-review
were finally determined and disagreements were resolved
by a further discussion among all the authors. The result
was that 20 articles were eventually included in this
mini-review and the search flow diagram was shown in
the supplementary Fig. 1.
Seasonal variations in low-density lipoprotein cholesterol
and high-density lipoprotein cholesterol
The most prevailing viewpoints support the seasonal
variations in the serum or plasma levels of HDL-C and
LDL-C. However, those results regarding the seasonal
patterns of HDL-C and LDL-C were contradictory to a
large extent.
Kreindl and his team conducted a follow-up study in
which the serum lipid profiles were measured in 50 vol-
unteers for 1 year at monthly intervals. Their findings
demonstrated that the levels of serum LDL-C were sig-
nificantly higher in winter and spring than in summer
and fall (p < 0.01) whereas the HDL levels were de-
creased markedly in winter (p < 0.05) [7].
Another study by Moura investigated 227,359 con-
secutive individuals who underwent health checkups in
primary care centers between 2008 and 2010. The re-
sults showed that the prevalence of LDL-C>130mg/dl
was 8% higher in winter than in summer (p < 0.001).
And the difference was even larger amongst females and
middle-aged individuals (p < 0.001). Besides, HDL-C<40
mg/dl were 9% more prevalent in summer (p < 0.001).
The variation amplitude of HDL-C was 3.4 ± 0.3 mg/dl
and 7.0 ± 2mg/dl for LDL-C. This finding presented the
evidence of biological rhythms and seasonal variations in
lipid profiles based on a large population sample [12].
Our team performed a longitudinal study using health
examination data of 5 consecutive years (47,270 sub-
jects) in Jinan, China. It was pointed out that for males
both the levels of HDL-C and LDL-C decreased signifi-
cantly for every 10 °C increase in air temperature (HDL-
Table 1 Summary of the included literature
Articles Refs Years Results (Summer) Results (Winter)
Kreindl C 7 2014 LDL: ↓; HDL: ↑ LDL: ↑; HDL: ↓
Moura FA 12 2013 LDL: ↓; HDL: ↑ LDL: ↑; HDL: ↓
Zhou X 6 2016 M: LDL: ↓; HDL: ↓; Cholesterol: ↓; Triglyceride: ↑
F: LDL: ↑; HDL: ↓; Cholesterol: ↑; Triglyceride: n.s.
M: LDL: ↑; HDL: ↑; Cholesterol: ↑; Triglyceride: ↓
F: LDL: ↓; HDL: ↑; Cholesterol: ↓; Triglyceride: n.s.
Hadaegh F 13 2006 LDL: ↓; Cholesterol: ↓; F: Cholesterol: n.s. LDL: ↑; Cholesterol: ↑; F: Cholesterol: n.s.
Joshi P 14 2014 LDL: ↓ LDL: ↑
Hopstock LA 15 2013 HDL: ↓ HDL: ↑
Chen SH 16 2006 HDL: ↓; Triglyceride: ↑ HDL: ↑; Triglyceride: ↓
Sasaki J 17 1983 LDL: ↓ (healthy men); HDL: ↓ (healthy men
and schizophrenic patients)
LDL: ↑ (healthy men); HDL: ↑ (healthy men and
schizophrenic patients)
Letellier G 18 1982 LDL: n.s.; HDL: n.s. LDL: n.s.; HDL: n.s.
Tung P 19 2009 LDL: n.s.; HDL: n.s. LDL: n.s.; HDL: n.s.
Fyfe T 9 1968 Cholesterol: ↓ Cholesterol: ↑
Thomas CB 20 1961 Cholesterol: ↓ Cholesterol: ↑
Fuller JH 21 1974 Cholesterol: n.s. Cholesterol: n.s.
Bull GM 10 1979 Cholesterol: n.s. Cholesterol: n.s.
Robinson D 11 1992 Cholesterol: ↓ Cholesterol: ↑
Garde AH 22 2000 Cholesterol: ↓ Cholesterol: ↑
Buxtorf JC 23 1988 Cholesterol: ↓ Cholesterol: ↑
Gordon DJ 24 1987 Cholesterol: ↓ Cholesterol: ↑
Ockene IS 25 2004 Cholesterol: ↓ Cholesterol: ↑
Valencia VE 5 2017 Cholesterol: ↓ Cholesterol: ↑
Footnotes: F female, M male, n.s not significant, ↑ high level or elevated, ↓ low level or decreased
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C: 0.18 mmol/L and LDL-C: 0.06 mmol/L). The values of
LDL-C might therefore reach its peak in winter. For fe-
males, there was an increase in the levels of LDL-C
(0.26 mmol/L) and a decrease in the levels of HDL-C
(0.32 mmol/L) for every 10 °C increase. Those classical
lipid-associated risk factors were adjusted before reach-
ing the conclusions, such as age, gender, diet, exercise,
blood pressure, body weight, change of body weight,
body mass index, glycemia, alanine aminotransferase and
creatinine. Thus air temperature might represent an in-
dependent influencing factor for LDL-C and HDL-C
levels and men and women are distinctly affected [6].
The same issue has been addressed to explore the sea-
sonal variability of serum lipids in adults in Tehran Lipid
and Glucose Study. It was a cross-sectional study
recruiting 2890 men and 4004 women aged 20 to 64
years from the Tehran Center for Fat and Blood Glucose
Study (TLGS) between 1999 and 2001. The LDL-C and
HDL-C values varied significantly in different seasons in
males, with higher LDL-C values in winter than in sum-
mer (p < 0.05). In females, the values of LDL-C and
HDL-C were consistent regardless of seasonality. The
prevalence of high LDL-C (>or = 160 mg/dl) was 26.7
and 24.9% respectively in men and women in winter,
Fig. 1 Summary of the prevailing opinions, potential mechanisms and clinical implications for the seasonal differences in blood lipids. 1)
Prevailing opinions:.Most reports supports that the levels of LDL-C and cholesterol were elevated in winter and were decreased in summer [6, 7,
12–17]. For HDL-C and triglyceride, the existing results were contradictory [5, 9, 10, 13, 15, 16, 18, 20–27, 31, 32, 38].. 2) Potential
mechanisms:.Accumulating evidence pointed towards an array of mechanisms for the seasonal variations of serum lipids, including air
temperature, physical activity, diet, blood volume, liver production of cholesterol and activity of lipid receptors and lipases, as well as other life
style-related factors [6, 11, 25, 33, 34].. 3) Clinical implications: The seasonal variations of serum lipids could lead to the diagnostic and treatment
biases, which include the delayed diagnosis and treatment as well as the aggressive use of lipid-lowering therapy. Firstly, for the individuals
whose lipid measures approach or reach the lower limit for therapy in the summer, another measurement is highly recommended in the winter.
Otherwise, a fraction of this group might experience a missed diagnosis and delayed treatment. Secondly, for the subjects whose lipid levels just
reach or are slightly above the lower limit for therapy in the winter, there might be a bias toward improperly classifying a portion of this group
as hypercholesterolemic in the winter. Thirdly, a higher possibility of treatment failure is expected when patients initiate treatment for
hypercholesterolemia during the summer and undergo follow-up during the winter [35–37].
Ma et al. Lipids in Health and Disease          (2020) 19:108 Page 3 of 8
which increased dramatically in both genders in winter
(p < 0.05). Interestingly, this study concluded that the
seasonal variability in serum lipid values might be
greater in men than in women. And the elevated preva-
lence of high LDL in winter in both sexes should be
taken into consideration in the prevention and treatment
of cardio-cerebrovascular diseases [13].
Another large-scale study by Joshi and his team ana-
lyzed the seasonal variations of blood lipoproteins in
2859,333 consecutive American adults recruited from
2006 to 2013 [14]. Particularly, the seasonal changes in
blood lipids were compared, as were the incidences of
abnormal LDL-C and HDL-C according to guidelines-
based goal attainment. Men and Women varied by about
2 and 4mg/dl for LDL-C and HDL-C, respectively. Simi-
larly, the levels of LDL-C peaked in winter and it might
lead to a variety of pathophysiological changes. However,
the authors concluded that the significance of clinical
guidance was not sufficient [14].
Hopstock observed 38,037 participants in a population-
based cohort from 1979 to 2008 in regards to seasonal
variations in the cardiovascular disease risk factors and
LDL-C were also on the list [15]. And a community-based
study was conducted to explore the summer-winter differ-
ences of component of metabolic syndrome and included
a total of 8251 residents aged 40 in Kinmen, Taiwan [16].
These two studies both indicated a peak time in winter of
HDL-C levels.
Sasaki et.al. studied the seasonal variations in serum li-
poproteins in schizophrenia patients and healthy sub-
jects. Their report demonstrated that the HDL-C levels
in summer and autumn were significantly lower than
those in winter and spring in both healthy men and
schizophrenic patients. And the concentration of LDL-C
was significantly higher in September and October as
compared with April in healthy men [17].
However, Letellier and his colleagues performed a 4-
year study of 2600 female individuals aged 30 to 39 years
and were unable to confirm the variations previously re-
ported [18]. Tung and his team re-examined the data
from the PROVE IT-TIMI 22 study and also detected no
significant difference in LDL-C when stratified by season
[19].
Seasonal variations of cholesterol
Studies on the seasonal variations of cholesterol have
been traced back to early decades. In 1960s, cholesterol
levels have been showed significantly higher in winter
than in summer in the general population [9, 20]. In
1971, Fuller with his team conducted an epidemiological
survey on 1005 healthy subjects and the effects of sea-
sonality on cholesterol and triglyceride levels were inves-
tigated [21]. Nevertheless, no obvious changes in the
cholesterol levels was found (deleted: noticed) between
different seasons in their studies. Subsequently, Bull and
his colleagues also obtained a consistent conclusion in
his investigation [10].
Since then a large quantity of studies have been per-
formed to explore the seasonal variations in cholesterol
and the most results advocated a higher level of choles-
terol in winter than in summer. Robinson et.al. per-
formed spectral analyses spanning over 4 years which
included 140,000 men and 32,000 women in the UK and
30,000 men and 12,000 women in Japan respectively.
The results demonstrated a strong seasonal effect on the
serum cholesterol levels, with average cholesterol levels
about 3–5% higher in winter than in summer. Besides,
monthly mean cholesterol level was negatively correlated
with monthly mean temperature. And the seasonal dif-
ferences in cholesterol levels were independent of body
weight and other potential confounding factors. It was
the first study on the seasonal variation of cholesterol
and the results were based on two large populations
which include more than 200,000 subjects. The findings
might have important implications for both long-term
epidemiological or follow-up studies as well as for the
interpretation of patient data [11]. The conclusions from
Robinson’s study have been subsequently confirmed by a
series of other studies [22–24].
A 12-month longitudinal study of seasonal variations
in blood lipids collected 517 healthy volunteers from a
health maintenance organization serving central Massa-
chusetts [25]. This study confirms the seasonal varia-
tions in the cholesterol levels both in men and women,
with a peak in winter. And the seasonal variations were
greater in women and hypercholesterolemic individuals
[25].
Hadaegh’s study also compared the levels of serum
cholesterol in different seasons. There existed a signifi-
cant trend for change in the values of cholesterol in
men, with higher cholesterol in winter than in summer.
The prevalence of hypercholesterolemia in the winter
was 26.2% higher than in summer in men. However, the
values of cholesterol were similar in women in different
seasons, suggesting a gender difference in seasonal vari-
ability of serum cholesterol levels [13].
Jerzy with his team collected one-year data of serum
cholesterol (304,156 data points) from the laboratories
in 14 districts in Poland. JEG, a primitive statistical
method (http://ibib.waw.pl/JEGen.html), was used to
give three levels of the Gaussian portion of any analytic
dataset (Gauss reference interval, GRI): low (GRImin),
modal or intermediate (GRIopt) and high (GRI-max).
Their results demonstrated the seasonal variability of
cholesterol levels in any analyzed subpopulation [26, 27].
Our research also pointed to the seasonal variations of
total cholesterol which decreased significantly for every
10 °C increase in air temperature (0.35 mmol/L for men
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and 0.73 mmol/L for women) [6]. From a mechanistic
point of view, seasonal variations in the lipid profile
might be explained by a set of seasonal alterations such
as hemodilution during the summer and hemoconcen-
tration in winter, as well as changes in dietary behaviors
and physical activities between different seasons [25, 28,
29]. We proposed that the annual air temperature fluc-
tuations might be an important mechanism of the sea-
sonal changes of lipids.
Valencia and his team conducted a cross-sectional
study of 3366 patients from January 2013 to December
2013. The average level of cholesterol was 180.62 mg/mL
in winter, 181.00 mg/mL in spring, 174.90 mg/mL in
summer and 179.22 mg/mL in autumn. The prevalence
of cholesterol level above the recommended limit was
24.86% in summer, 28.40% in autumn, 31.43% in winter
and 31.86% in spring [5].
Seasonal variations in triglyceride
The studies on the seasonal variations of TG have pro-
duced conflicting results with no consensus at present.
More intensive investigation is required to resolve this
issue. Although a prevailing view supports the levels of
TG characteristic of seasonal variations, its peak time re-
mains largely undermined.
In Chen’s study summer was positively associated with
the occurrence of hypertriglyceridemia [16]. Our investi-
gation also emphasized that TG levels increased signifi-
cantly for every 10 °C increase in air temperature (0.12
mmol/L for men and not affected by air temperature
amongst women), suggesting a peak time of TG in sum-
mer [6]. However, in Hopstock’s survey, TG levels
reached its peak in autumn [15].
Letellier’s work showed that for women aged 30 to 39
years, TG was 6% higher in spring than in autumn.
Nevertheless, men aged 30 to 39 years had a 22% higher
TG in winter than in autumn. The difference was
smaller for younger men, and not significant for men
aged 20 to 25 years [18].
Seasonal variations of blood lipids in patients
Most studies above explored the seasonal variations of
blood lipids in healthy subjects. Are there seasonal alter-
ations of blood lipids when it comes to patients with
basic diseases?
Bardini et.al. investigated the seasonal variability of
blood lipids in patients with type 2 diabetes mellitus
(DM). The results demonstrated a peak of cholesterol,
LDL-C and TG levels in fall and winter, during which
HDL-C levels were reduced. To our knowledge, this was
the first report showing seasonal changes in lipid profile
in type 2 DM outpatients taking or not taking statins.
Hence the seasonal variations of lipids might not be ex-
clusive to healthy individuals [30].
Sangha with his team examined the seasonal trends in
HbA1c and other metabolic parameters in a cohort of
patients with Type 1 DM From 2008 to 2013. It was a
retrospective analysis of outpatients attending clinic at a
large tertiary referral hospital in the UK. At each clinic
visit, HbA1c and other metabolic parameters including
cholesterol, TG, creatinine, blood pressure and body
mass index were measured. Their findings showed no
significant seasonal effect on the metabolic parameters
except for HbA1c [31].
A Japanese study investigating a total of 1202 patients
with metabolic syndrome showed that serum levels of
HDL-C was significantly higher in winter than in sum-
mer. This result directly supported to the notion that
seasonal variation in metabolic parameters affects the
diagnosis of metabolic syndrome [31].
Besides, a study on the seasonal variations of serum
lipids in renal transplant recipients (RTR) was performed
because this group of patients were at high risk for
hyperlipidemia. Their results found that RTR do not ex-
hibit seasonal variations in lipids, unlike the general
population. The seasonal effects might be suppressed by
the factors unique to RTR such as immunosuppressive
therapies etc. [32]
The significance of seasonal variations of serum lipids in
clinical practice
Despite that for decades numerous studies have reported
the seasonal variations of serum lipids, the mechanisms
of seasonal changes in the metabolism of lipids are not
fully determined. And there exist considerable concerns
about the consistency and validity of those findings. Be-
sides, the seasons of serum lipid measurements should
be given consideration in the diagnosis and management
decisions in clinical practice (Additional file 1).
The changes in air temperature have been noted to
contribute to the seasonal variations in lipid levels. Rob-
inson and our work both reported the negative correl-
ation of air temperature and cholesterol levels [6, 11].
Additionally, seasonal variations in physical activity, diet
and other life style-related factors appeared to explain a
small fraction of the observed seasonal variations in
blood lipid levels [25]. Importantly, these potential co-
variates, especially temperature and physical activity,
might synergistically lead to the alterations in the blood
volumes, an effect further resulting in a decrease of choles-
terol levels in summer as a consequence of hypervolemia
and an increased level in winter due to hemoconcentration
[33]. Besides, the seasonal variabilities of serum lipids
might also be attributed from the seasonal alterations in
the liver production of cholesterol as well as activity of lipid
receptors and lipases [34].
In routine clinical practice, measuring the serum chol-
esterol levels is crucial in establishing the diagnosis of
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hypercholesterolemia and evaluating the efficacy out-
comes of lipid-lowering therapy. Thanks to the seasonal
alterations of serum lipid profiles, difference in the
prevalence of hypercholesterolemia in different seasons
could produce misclassification for hypercholesterol-
emia. And this misclassifcation unavoidably leads to
diagnostic and treatment biases [29]. In one respect, the
bias is connected with the delayed onset of therapeutic
intervention and an augmented risk of cardiovascular
and cerebrovascular events. In another aspect, aggressive
administration of lipid-lowering drugs might occur and
result in unnecessary medical expense, adverse reaction
and drug toxicity. This raises the concern about adjust-
ing the diagnosis criterion of hypercholesterolemia and
therapy stragety according to the seasonal transform-
ation. However, no consensus has been to date reached,
nor has any guidelines clearly addressed this issue. Add-
itionally, an interesting question might also be put for-
ward: is it the actual serum lipid concentration or
absolute amount of cholesterol carried in the circulatory
system that is the genuine culprit in hypercholesterol-
emia? This question awaits for further elucidation and
season-specific guidelines have to be adjusted in the fu-
ture [25].
Based on the prevailing viewpoint of seasonal varia-
tions in the levels of serum cholesterol, we summarized
several point views of lipid management (delete: re-
minders) from the clinician’s perspective. These opinions
should be interpreted cautiously because the necessity of
clinical intervention due to the seasonal changes of
blood lipids is still undetermined given the small and
heterogeneous amount of evidence. Firstly, for the indi-
viduals whose lipid measures approach or reach the
lower limit for therapy in the summer, another measure-
ment is highly recommended in the winter. Otherwise, a
fraction of this group might experience a missed diagno-
sis and delayed treatment. One study suggested that the
subjects who are obese, current smoker, advanced in age
or carring other well-documented risk factors should
particularly consider a repeated serum lipid test in win-
ter [35]. Secondly, for the subjects whose lipid levels just
reach or are slightly above the lower limit for therapy in
the winter, there might be a bias toward improperly clas-
sifying a portion of this group as hypercholesterolemic
in the winter. Additionally, more individuals are subject
to the diagnostic and treatment selection biases in win-
ter because more adverse cardiovascular and cerebrovas-
cular events occur during the winter months. One team
estimated that this misclassification of cholesterol status
due to seasonal variation might result in approximately
800 thousand people likely being administrated for
hypercholesterolemia in winter at a cost of 840 million
dollars in drug treatment alone in the United States [36].
The expense would be huge for the developing
countries, needless to say the adverse reaction and drug
toxicity from aggressive therapy. Thus for this group, the
advent of treatment should be cautious by comprehen-
sively assessing the risk of adverse events and benefit of
therapy. Thirdly, a higher possibility of treatment failure
is expected when patients initiate treatment for hyper-
cholesterolemia during the summer and undergo follow-
up during the winter. It is still not evidence-based that
whether or not the lipid-lowering therapy should be in-
tensified or maintained with former dosages for this
group in winter. And it is worthy of discussion that
whether a season-based individual-tailered therapy strat-
egy is better to adapt to the seasonal alterations of chol-
esterol. For this purpose, it was highlighted to pay more
attention to LDL-C levels rather than on total choles-
terol levels, in order to decrease the chance of misclassi-
fication. It is because the magnitude of order of LDL-C
is lower than that of total cholesterol [37].
Writing a systematic review with meta-analysis is def-
initely a wise option and an ideal way for this topic.
However, after article search and quality assessment, it
was found impossible to pool the results using meta-
analysis and obtain a trustworthy conclusion. The reason
lies in the obvious heterogeneity between these included
studies as follows: 1) a wide time span from 1968 to
2018; 2) various ethnicities or coutries from Europeans
to Asians; 3) different testing methods of blood lipids; 4)
distinct study quality from low to high; 5) last but not
least, outcomes or parameters not identical for statistical
pooling. A simple example is that different ethnicities
are different in the diet structures, living environments,
education levels, fitness habits and especially genetic
backgrounds, which might have huge influences on the
blood lipids and lead to potential bias to the meta-
analysis. Hence, if these studies are statistically merged
for a meta-analysis, the pooling results will be evidently
heterogeneous and not be convincing. Besides, subgroup
analysis could be applied to resolve the problem of het-
erogeneity. However, we estimate that there would be
too few studies in each subgroup and therefore the re-
sults of meta-analysis would be not reliable. In the near
future such a meta-analysis of suitable studies might be
performed for the seasonality of blood lipid.
Conclusions
Most current studies advocated that the season might be
a fundamental factor in the changes of blood lipids. And
the seasonal differences in blood lipids might be most
obvious between winter and summer. There is a cer-
tainty that subjects with different ages and genders are
distinctly affected by seasonality with regards to blood
lipids. At present, the detailed seasonal patterns of blood
lipids are still controversy. The seasonal increase in LDL
and cholesterol levels in winter might potentially and
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partially account for the increased mortality and morbid-
ity of cardiovascular and cerebrovascular diseases in
winter. From the clinical viewpoint, such amplitude of
variations in lipid profile must be considered in the dis-
ease prevention and treatment. Besides, the mechanisms
of the alterations in blood lipids with the seasons have
not yet been established. Further studies with higher
quality in research design and larger sample sizes, as well
as those studies focused on the mechanisms of this sea-
sonal variability (delete: relevant basic researches), are
desperately required to resolve these puzzles.
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